Effect of Macro-Cyclic Bifunctional Chelators DOTA and NODAGA on Radiolabeling and <i>In Vivo</i> Biodistribution of Ga-68 Cyclic RGD Dimer
Rakhee Vatsa(Post Graduate Institute of Medical Education and Research), Bhagwant Rai Mittal(Government of Haryana), Jaya Shukla(Rutgers, The State University of New Jersey), Gurpreet Singh(Post Graduate Institute of Medical Education and Research), Sudipta Chakraboarty(Bhabha Atomic Research Centre), Ashutosh Dash(Bhabha Atomic Research Centre)
Cited by 9
Related Papers
Production of 177Lu for Targeted Radionuclide Therapy: Available Options
|Nuclear Medicine and Molecular Imaging|2015|375
Sustained Availability of <sup>99m</sup>Tc: Possible Paths Forward
|Journal of Nuclear Medicine|2012|140
Antimicrobial Stewardship Programs in Resource Constrained Environments: Understanding and Addressing the Need of the Systems
|Frontiers in Public Health|2020|134
Peptide Receptor Radionuclide Therapy: An Overview
|Cancer Biotherapy and Radiopharmaceuticals|2015|122
Targeted Radionuclide Therapy - An Overview
|Current Radiopharmaceuticals|2013|117